IS8827A - 2-(1H-indólýlsúlfanýl)-bensýl amín afleiður sem valvís serótónín endurupptöku hindri (SSR). - Google Patents

2-(1H-indólýlsúlfanýl)-bensýl amín afleiður sem valvís serótónín endurupptöku hindri (SSR).

Info

Publication number
IS8827A
IS8827A IS8827A IS8827A IS8827A IS 8827 A IS8827 A IS 8827A IS 8827 A IS8827 A IS 8827A IS 8827 A IS8827 A IS 8827A IS 8827 A IS8827 A IS 8827A
Authority
IS
Iceland
Prior art keywords
indolylsulfanyl
ssr
serotonin reuptake
reuptake inhibitor
amine derivatives
Prior art date
Application number
IS8827A
Other languages
English (en)
Other versions
IS2815B (is
Inventor
Jan Kehler
Karsten Juhl
Jimmy Sejberg
Morten Bang Noergaard
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of IS8827A publication Critical patent/IS8827A/is
Publication of IS2815B publication Critical patent/IS2815B/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS8827A 2003-12-23 2009-06-05 2-(1H-indólýlsúlfanýl)-bensýlamínafleiður sem valvís serótónín endurupptökuhindri (SSRI). IS2815B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53259303P 2003-12-23 2003-12-23
DKPA200301923 2003-12-23

Publications (2)

Publication Number Publication Date
IS8827A true IS8827A (is) 2009-06-05
IS2815B IS2815B (is) 2012-11-15

Family

ID=36603121

Family Applications (2)

Application Number Title Priority Date Filing Date
IS8467A IS2551B (is) 2003-12-23 2006-05-15 2-(1H-indólýlsúlfanýl)-bensýl amín afleiður sem valvís serótónín endurupptöku hindri (SSRI)
IS8827A IS2815B (is) 2003-12-23 2009-06-05 2-(1H-indólýlsúlfanýl)-bensýlamínafleiður sem valvís serótónín endurupptökuhindri (SSRI).

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IS8467A IS2551B (is) 2003-12-23 2006-05-15 2-(1H-indólýlsúlfanýl)-bensýl amín afleiður sem valvís serótónín endurupptöku hindri (SSRI)

Country Status (24)

Country Link
EP (1) EP1860100B1 (is)
KR (2) KR20080092471A (is)
CN (2) CN101372474A (is)
AR (1) AR046978A1 (is)
AT (1) ATE500220T1 (is)
CA (1) CA2551168C (is)
DE (1) DE602004031680D1 (is)
DK (1) DK1860100T3 (is)
EA (2) EA010666B1 (is)
ES (1) ES2362237T3 (is)
HK (1) HK1103075A1 (is)
IS (2) IS2551B (is)
ME (1) ME01040B (is)
MY (1) MY143038A (is)
NO (1) NO336676B1 (is)
NZ (1) NZ547046A (is)
PL (1) PL1860100T4 (is)
PT (1) PT1860100E (is)
RS (1) RS51899B (is)
SG (1) SG141463A1 (is)
SI (1) SI1860100T1 (is)
TW (1) TWI347183B (is)
UA (1) UA82920C2 (is)
ZA (1) ZA200705870B (is)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101224201B (zh) * 2007-01-18 2011-10-05 和泓生物技术(上海)有限公司 多巴胺转运蛋白和去甲肾上腺素转运蛋白双重抑制剂的应用
CN103201262B (zh) * 2010-08-20 2016-06-01 艾米拉医药股份有限公司 自分泌运动因子抑制剂及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803143A (en) 1969-09-08 1974-04-09 Eisai Co Ltd 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines
US4018830A (en) 1969-09-22 1977-04-19 Merck & Co., Inc. Phenylthioaralkylamines
US4055665A (en) 1974-11-25 1977-10-25 Merck & Co., Inc. Treating arrythmia with phenylthioaralkylamines
US4056632A (en) 1975-07-21 1977-11-01 Burroughs Wellcome Co. 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use
EP0396827A1 (en) 1989-05-09 1990-11-14 SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu 2-Phenylthiobenzylamine dervivatives and acid addition salts thereof
GB8912971D0 (en) 1989-06-06 1989-07-26 Wellcome Found Halogen substituted diphenylsulfides
GB9126311D0 (en) 1991-12-11 1992-02-12 Wellcome Found Substituted diphenylsulfides
CZ293595A3 (cs) 1995-11-09 1999-12-15 Farmak A. S. Deriváty N,N-dimethyl-2-(arylthio)benzylaminu, jejich soli, způsoby jejich přípravy a jejich použití v léčivých přípravcích
US5912256A (en) * 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems
JP2000516936A (ja) * 1996-08-27 2000-12-19 アメリカン・ホーム・プロダクツ・コーポレイション ドパミンd2作動薬としておよび5―ht1aリガンドとしての4―アミノエトキシインドール
ES2264259T3 (es) 1999-04-30 2006-12-16 Trustees Of The University Of Pennsylvania Agentes de obtencion de imagenes por spect (tomografia por emision de foton unico) para transportador de serotonina.
US6410736B1 (en) 1999-11-29 2002-06-25 Pfizer Inc. Biaryl ether derivatives useful as monoamine reuptake inhibitors
US6436938B1 (en) 2001-01-22 2002-08-20 Pfizer Inc. Combination treatment for depression

Also Published As

Publication number Publication date
IS2551B (is) 2009-10-15
IS8467A (is) 2006-05-15
DE602004031680D1 (de) 2011-04-14
DK1860100T3 (da) 2011-06-14
EP1860100B1 (en) 2011-03-02
ATE500220T1 (de) 2011-03-15
MY143038A (en) 2011-02-28
ZA200705870B (en) 2009-09-30
EP1860100A3 (en) 2007-12-05
RS51899B (en) 2012-02-29
TWI347183B (en) 2011-08-21
AR046978A1 (es) 2006-01-04
NZ547046A (en) 2010-04-30
CN100591666C (zh) 2010-02-24
CN1898204A (zh) 2007-01-17
EA200702258A1 (ru) 2008-02-28
NO336676B1 (no) 2015-10-19
EA012752B1 (ru) 2009-12-30
UA82920C2 (en) 2008-05-26
PL1860100T4 (pl) 2011-09-30
ES2362237T3 (es) 2011-06-30
CA2551168C (en) 2011-09-13
PT1860100E (pt) 2011-05-25
EA010666B1 (ru) 2008-10-30
HK1103075A1 (en) 2007-12-14
NO20063405L (no) 2006-07-24
PL1860100T3 (pl) 2011-07-29
CN101372474A (zh) 2009-02-25
IS2815B (is) 2012-11-15
SG141463A1 (en) 2008-04-28
EA200601226A1 (ru) 2006-10-27
EP1860100A2 (en) 2007-11-28
KR20060118529A (ko) 2006-11-23
KR100872022B1 (ko) 2008-12-05
TW200607499A (en) 2006-03-01
KR20080092471A (ko) 2008-10-15
CA2551168A1 (en) 2005-07-07
ME01040B (me) 2010-05-07
SI1860100T1 (sl) 2011-06-30

Similar Documents

Publication Publication Date Title
LTC1436271I2 (lt) Fenilpiperazino dariniai, kaip serotonino grįžtamos absorbcijos inhibitoriai
NO20034307L (no) Cyklopropylindol-derivater som selektive serotonin- gjenopptaksinhibitorer
NO20053775D0 (no) Diazepinoindol derivater som kinaseinhibitorer.
DK1902037T3 (da) 2,4-diamino-pyrimidiner som auroainhibitorer
NO20044654L (no) Piperidinoylpiperidiner som 5-HTIF-agonister
DK1492785T3 (da) 2-hydroxy-3-heteroarylindol-derivater som GSK3-inhibitorer
DK2094263T3 (da) 2-adamantyl-butyramidderivater som selektive 11 beta-hsd1-inhibitorer
DK1501826T3 (da) Substituerede indoler som alpha-1-agonister
DK1846394T3 (da) Pyrazolylaminopyridinderivater, der er egnede som kinaseinhibitorer
DK1638933T3 (da) N-pyrrolidin-3-yl-amid-derivater som serotonin- og noradrenalin-genoptagelses inhibitorer
DK2407451T3 (da) N,N-substituerede 3-aminopyrrolidin-forbindelser anvendelige som monoamin-genoptagelseshæmmere
NO20030842D0 (no) Fenoksybenzylamin-derivater som selektive serotonin- gjenopptaksinhibitorer
DK1954668T3 (da) Homo- og heterocykliske forbindelser, der er egnede som CETP-inhibitorer
DK1511718T3 (da) N-acylaminobenzenderivater som selektive monoaminoxidase B-inhibitorer
IS8827A (is) 2-(1H-indólýlsúlfanýl)-bensýl amín afleiður sem valvís serótónín endurupptöku hindri (SSR).
DK1613594T3 (da) 4-(2-Phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridin derivater som serotonin-genoptagelseshæmmere
NO20053911D0 (no) Diazepinderivater som er nyttige som LFA inhibitorer.
DK1682523T3 (da) Morpholin-derivater som noradrenalin-genoptagelsesinhibitorer
ES1053758Y (es) Envase para golosinas.
ES1055902Y (es) Colgador para piezas carnicas.
DK1377550T3 (da) Phenyl-heterocyclyletherderivater som serotonin-re-uptakeinhibitorer
ES1056419Y (es) Revestimiento laminar para envases.
ES1055209Y (es) Envase perfeccionado para botellas.
ES1052538Y (es) Contenedor abierto, para estructuras de andamio
ES1054928Y (es) Pallon para gaita.